利伐沙班医保报销比例？

Rivaroxaban is a highly selective, oral drug that directly inhibits factor Xa. By inhibiting factor Rivaroxaban does not inhibit thrombin (activated factor II) and has no proven effect on platelets. A dose-dependent inhibition of factor Xa activity by rivaroxaban has been observed in humans. The effect of rivaroxaban on prothrombin time (PT) has a dose-effect relationship. If NeopLastin is used for content measurement, it is closely related to the plasma concentration (correlation coefficient is 0.98). Different results may occur with other reagents. Reading the PT should be completed within seconds because the International Normalized Ratio (INR) is calibrated and validated only for coumarins and not for other anticoagulants.

Rivaroxaban tablets were approved for sale by the State Food and Drug Administration in March 2009, and were successfully included in the 2009 National Medical Insurance Catalog in the same year. Rivaroxaban belongs to Category B of medical insurance. The insured person will first pay a certain proportion of the cost of using this type of drug, and then it will be included in the scope of payment of the basic medical insurance fund, and the fees will be paid in accordance with the provisions of the basic medical insurance. What is the reimbursement rate for rivaroxaban by medical insurance?

It is understood that rivaroxaban has three specifications. Different specifications of rivaroxaban have different reimbursement ratios, and the reimbursement ratios of rivaroxaban sold in different regions are also different. Rivaroxaban has a specification of 10mg-5 tablets/box, and the newly launched price is around 330$, and the price after medical insurance is about 138$, with a reimbursement ratio of 58%; Rivaroxaban has a specification of 15mg-7 tablets/box, and the newly launched price is 570$ The price after medical insurance is about $195, and the reimbursement rate is 65%; Rivaroxaban has a specification of 20 mg-7 tablets/box, and the price when it is first launched is about $700. The price after medical insurance is about $250, and the reimbursement rate is 65%.